Artemis Medicare Services Limited Stock
Stocks
ARTEMISMED
INE025R01021
Healthcare Facilities & Services
|
Market Closed -
NSE India S.E.
06:05:06 2026-11-12 EST
|
5-day change | 1st Jan Change | ||
| 316.75 INR | +1.04% |
|
+5.50% | +16.86% |
| Market Cap | 50.14B 533M 482M 445M 403M 760M 783M 5.34B 2.12B 26.81B 2B 1.96B 85.33B | P/E 2027 * |
37.1x | P/E 2028 * | 25.5x |
|---|---|---|---|---|---|
| Enterprise Value | 50.14B 533M 482M 445M 403M 760M 783M 5.34B 2.12B 26.81B 2B 1.96B 85.33B | EV / Sales 2027 * |
3.76x | EV / Sales 2028 * | 2.99x |
| Free-Float |
19.15% | Yield 2027 * |
0.14% | Yield 2028 * | 0.14% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| ARTEMISMED | Delayed | |
Bombay S.E.
| ARTEMISMED | Delayed |
| 1 day | +1.04% | ||
| 1 week | +5.50% | ||
| Current month | +8.03% | ||
| 1 month | +1.13% | ||
| 3 months | +1.10% | ||
| 6 months | +12.67% | ||
| Current year | +16.86% |
| 1 week | 296.85 |  | 318.8 |
| 1 month | 276 | | 318.8 |
| Current year | 203.35 | | 378.8 |
| 1 year | 203.35 | | 378.8 |
| 3 years | 141.3 | | 378.8 |
| 5 years | 33 | | 378.8 |
| 10 years | 10.67 | | 378.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Chief Tech/Sci/R&D Officer | - | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 2008-01-16 | |
| Chairman | 84 | 2006-09-13 | |
| Director/Board Member | - | 2006-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.04% | +5.50% | +25.72% | +96.68% | 529M | |
| +0.13% | +10.35% | +11.82% | +32.37% | 115B | |
| -0.68% | -0.84% | +6.25% | +118.80% | 106B | |
| +0.33% | -11.54% | +53.60% | +562.94% | 46.38B | |
| +0.68% | +2.80% | +8.04% | +110.94% | 33.01B | |
| -0.13% | +2.28% | +39.69% | +81.78% | 30.23B | |
| +0.43% | +2.08% | +39.17% | +96.48% | 28.46B | |
| -1.63% | +0.79% | +44.36% | +426.17% | 23.32B | |
| +0.33% | +0.09% | -18.10% | -16.30% | 19.85B | |
| +1.42% | +0.77% | -5.54% | +33.11% | 16.77B | |
| Average | +0.19% | +0.08% | +20.50% | +154.30% | 42B | |
| Weighted average by Cap. | -0.04% | +1.32% | +18.33% | +146.79% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 13.32B 142M 128M 118M 107M 202M 208M 1.42B 564M 7.12B 532M 521M 22.67B | 16.76B 178M 161M 149M 135M 254M 262M 1.79B 710M 8.96B 669M 655M 28.52B |
| Net income | 1.33B 14.12M 12.76M 11.78M 10.67M 20.13M 20.73M 141M 56.2M 709M 52.98M 51.85M 2.26B | 1.93B 20.54M 18.57M 17.14M 15.52M 29.28M 30.16M 206M 81.77M 1.03B 77.08M 75.44M 3.29B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-12 | ₹316.75 | +1.04% | 119,267 |
| 26-11-11 | ₹313.50 | +1.64% | 124,714 |
| 26-11-09 | ₹308.45 | -2.37% | 85,667 |
| 26-11-08 | ₹315.95 | +3.22% | 55,998 |
| 26-11-06 | ₹306.10 | +1.63% | 195,208 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARTEMISMED Stock
Select your edition
All financial news and data tailored to specific country editions
